Page 18 - EJMO-9-1
P. 18

Eurasian Journal of Medicine and
            Oncology
                                                                             Single-cell RNA-seq in malignant skin tumors


            scMet has been developed to facilitate the deconvolution   clinical research, ultimately advancing our understanding
            of bulk RNA-Seq data into single-cell RNA-Seq profiles.   of tumor diversity and progression.
            This method provided unique spatial insights into
            metabolic heterogeneity in the microenvironment of   Acknowledgments
            renal cell tumors. While this method provides valuable   We thank all the authors of the cited references. Graphs
            insights into the relative proportions of major cell types   were created using BioRender.
            within a sample, it has notable limitations. For instance,
            it cannot accurately capture the detailed composition   Funding
            and dynamic changes of the TME, nor does it provide a   This study is jointly supported by the Natural Science
            comprehensive view of the molecular alterations within   Foundation of China (grant no. 32200523), Chongqing
            the microenvironment or the complex interactions   Natural Science Foundation (grant no. CSTB2023NSCQ-
            between cells. Another team integrated scRNA-seq, bulk   MSX0658), the Fundamental Research Funds for the
            RNA-seq,  whole  exome  sequencing,  DNA  methylation   Central Universities  (grant no. 2023CDJYGRH-YB05),
            analysis,  spatial  transcriptomics,  and  spatial  proteomics   Chongqing Wanzhou Municipal Science, and Health
            to create a comprehensive cellular map of neuroblastoma.   Joint Medical Research Project General Program
            Methylation  analysis  revealed  heterogeneity  of  (wzstc-kw2023004).
            neuroblastoma malignancy, while spatial analysis showed
            immune cells adjacent to stromal cells, separated from   Conflict of interest
            proliferating sympathetic neuroblastoma and adrenergic
                      89
            neuron cells.  Therefore, future advancements in single-  The authors declare that they have no competing interests.
            cell sequencing technology, coupled with its integration   Author contributions
            with other omics approaches, will continue to drive
            progress in skin tumor research, providing novel insights   Conceptualization: Mingzhu Yin, Xin Li
            for diagnosis and prevention. 90-92                Data curation: Lanlan Liu, Jie Sun
                                                               Formal analysis: All authors
            7. Conclusion                                      Funding acquisition: Chunlan Hu
            Single-cell  technology  represents  a  significant  Investigation: All authors
            advancement in the life sciences, allowing researchers to   Methodology: All authors
            transition from tissue-level to cellular-level research. The   Project administration: Xin Li, Mingzhu Yin
            rapid development of this technology has greatly enhanced   Supervision: Xin Li, Mingzhu Yin
            our understanding of the heterogeneity of skin tumor cells   Visualization: Lanlan Liu
            and the intricate TME. Immunotherapy targeting the   Writing – original draft: Jie Sun, Lanlan Liu, Xin Li
            TME has shown powerful therapeutic effects in various   Writing – review & editing: Mingzhu Yin, Xin Li, Jie Sun,
            cancers, including skin tumors. The integration of single-  Lanlan Liu
            cell technology with other omics approaches allows a more   Ethics approval and consent to participate
            comprehensive exploration of the cellular heterogeneity
            composition and complex cell-to-cell interactions within   Not applicable.
            the TME. This integration provides unique insights
            into the mechanisms underlying tumor development   Consent for publication
            and spread, facilitating the prediction of individualized   Not applicable.
            treatment responses, the discovery of new therapeutic
            strategies, and the enhancement of treatment efficacy.   Availability of data
            However, there are several challenges within this field, such   Not applicable.
            as  the efficiency  of single-cell isolation and  capture,  the
            complexity of single-cell sequencing data, the static nature   References
            of current technologies, limited spatial resolution, and the
            scarcity of certain cell populations. These issues could lead   1.   Dlugosz A, Merlino G, Yuspa SH. Progress in cutaneous
                                                                  cancer research. J Investig Dermatol Symp Proc. 2002;7(1):
            to misleading results. While scRNA-seq has become an   17-26.
            important tool in cancer research, further improvements
            are needed in both the precision of the technology and      doi: 10.1046/j.1523-1747.2002.19631.x
            the methods for data analysis. Enhancing these aspects   2.   Sawada Y, Nakamura M. Daily lifestyle and cutaneous
            will allow single-cell technology to play a greater role in   malignancies. Int J Mol Sci. 2021;22(10):5227.


            Volume 9 Issue 1 (2025)                         10                              doi: 10.36922/ejmo.5809
   13   14   15   16   17   18   19   20   21   22   23